gptkbp:instanceOf
|
chemical company
|
gptkbp:acquisition
|
gptkb:Chugai_Pharmaceutical
gptkb:Synthelabo
gptkb:Roussel_Uclaf
Aventis
Genzyme
Cyanamid
|
gptkbp:collaboratedWith
|
Rhodia
|
gptkbp:dissolved
|
1999
|
gptkbp:employees
|
around 50,000 (1999)
|
gptkbp:founded
|
1863
|
gptkbp:headquarters
|
gptkb:Frankfurt,_Germany
|
https://www.w3.org/2000/01/rdf-schema#label
|
Hoechst AG
|
gptkbp:industry
|
pharmaceuticals
|
gptkbp:keyPeople
|
gptkb:Wolfgang_W._Wiegand
|
gptkbp:location
|
gptkb:Germany
|
gptkbp:parentCompany
|
Sanofi
|
gptkbp:partnerships
|
gptkb:GlaxoSmithKline
gptkb:AstraZeneca
gptkb:Johnson_&_Johnson
gptkb:Zymeworks
gptkb:Takeda_Pharmaceutical_Company
gptkb:Bayer_AG
gptkb:Boehringer_Ingelheim
gptkb:Bristol-Myers_Squibb
gptkb:Pfizer
gptkb:Mylan_N.V.
gptkb:Teva_Pharmaceutical_Industries
gptkb:Roche
gptkb:Amgen
gptkb:Sandoz
gptkb:Hikma_Pharmaceuticals
gptkb:Astellas_Pharma
gptkb:Eli_Lilly_and_Company
gptkb:UCB_S.A.
gptkb:Sierra_Oncology
gptkb:Mitsubishi_Tanabe_Pharma
Novartis
Sanofi
AbbVie
Merck KGaA
|
gptkbp:previousName
|
gptkb:Friedrich_Hoechst_AG
|
gptkbp:products
|
chemicals
biotechnology products
medicines
|
gptkbp:revenue
|
€ 12 billion (1999)
|
gptkbp:subsidiary
|
gptkb:Boehringer_Ingelheim
|
gptkbp:successor
|
Sanofi-Aventis
|
gptkbp:type
|
public company
|
gptkbp:website
|
www.hoechst.com
|